If you or a loved one were diagnosed with ductal carcinoma after taking Zantac, you may be entitled to recover compensation from a Zantac ductal carcinoma lawsuit or settlement.
A team of heartburn drug injury lawyers and class action attorneys is investigating potential lawsuit and settlement cases of women who were diagnosed with invasive ductal carcinoma after taking Zantac for heartburn.
Ductal carcinoma is a form of breast cancer that begins in the milk ducts which supply milk from milk-producing lobules to the nipple.
Invasive ductal carcinoma (also known as infiltrating ductal carcinoma) is a form of breast cancer that has spread from the milk ducts and invaded surrounding breast tissue. Invasive ductal carcinoma is the most common type of breast cancer, accounting for almost 80% of all breast cancers. It is estimated that there about 180,000 invasive ductal carcinoma cases diagnosed each year in the U.S.
Ductal carcinoma in situ (also known as intraductal carcinoma or stage 0 breast cancer) is a form of breast cancer that hasn’t spread to surrounding breast tissue. It is estimated that there about 60,000 ductal carcinoma in situ cases diagnosed each year in the U.S.
Zantac Ductal Carcinoma Lawsuit Cases
Zantac ductal carcinoma lawsuit and settlement cases potentially being investigated include claims of individuals who took recalled Zantac for heartburn and suffered serious injuries, side-effects or complications including, among others:
- Invasive ductal carcinoma (IDC)
- Medullary Ductal Carcinoma
- Mucinous Ductal Carcinoma
- Papillary Carcinoma
- Tubular Ductal Carcinoma
If you or someone you love took Zantac and suffered from Invasive Ductal Carcinoma, you may be entitled to compensation from a Zantac Ductal Carcinoma lawsuit or settlement. Contact a drug injury lawyer to request a free case review.
*If you or a loved one are experiencing health issues, side effects or complications after taking a prescription drug or medication, we urge you to promptly consult with your doctor or physician for an evaluation.
**The listing of a company (e.g., Sandoz, Sanofi, Pfizer, GlaxoSmithKline, Apotex, Perrigo, Lannett, Novitium, Allergan) or product (e.g., Zantac or Ranitidine) is not meant to state or imply that the company acted illegally or improperly or that the product is unsafe or defective; rather only that an investigation may be, is or was being conducted to determine whether legal rights have been violated.
***The use of any trademarks, tradenames or service marks is solely for product identification and/or informational purposes.
Fill out the form for a free attorney review.